USPTO serial 76075378
Serial No. 76075378
Reviewed by CopyMark Law Group
Reg. 2623068Status 710
- Filing date
- Status date
- Registration date
- Sep 24, 2002
- Examiner
- LEIPZIG, MARC J
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 76075378?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CLERMOND-FERRAND, FR
CLERMOND-FERRAND, FR
CLERMOND-FERRAND, FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of photographic materials, namely, paints, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, colorings, cosmetics, glues, and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil preparation agents and fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, proteins in the nature of growth hormones for plants, animals and microbes and growth inhibitors and regulators; chemicals for use in the manufacture of diagnostic reagents, cell culture media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, and genetic expression amplifiers | SECTION 8 - CANCELLED | — |
| 003 | Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or in imunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies | SECTION 8 - CANCELLED | — |
| 042 | Biological and biotechnological laboratory research services, namely genetic modification of plants and plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research and tests regarding genetically modified plants; laboratory research featuring the expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 18, 2009 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Feb 2, 2009 | PAPER RECEIVED | — | |
| Dec 11, 2007 | CFIT | CASE FILE IN TICRS | — |
| Sep 24, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 2, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 12, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 30, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2001 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 23, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2001 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Dec 18, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2000 | DOCK | ASSIGNED TO EXAMINER | — |